Sergey A. Kaliberov

1.1k citations

25 papers · 825 indexed · 1 hit paper · h-index 15

Co-authors: Lyudmila N. Kaliberova David T. Curiel Sergei Kusmartsev Victor Prima Donald J. Buchsbaum Valentina Krendelchtchikova Cecil R. Stockard William E. Grizzle
Topics: Virus-based gene therapy research (18 papers)Cancer Research and Treatments (9 papers)CAR-T cell therapy research (8 papers)
Cited by: Immunology Biotechnology Oncology
Journals: Proceedings of the National Academy of Sciences PLoS ONE Virology
Partner nations: United States United Kingdom Belgium

In The Last Decade

Sergey A. Kaliberov

24 papers receiving 816 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

COX2/mPGES1/PGE ₂ pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells

2017 374 citations Victor Prima, Lyudmila N. Kaliberova et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by Sergey A. Kaliberov

Since Specialization

Citations

This map shows the geographic impact of Sergey A. Kaliberov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergey A. Kaliberov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergey A. Kaliberov more than expected).

Fields of papers citing papers by Sergey A. Kaliberov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergey A. Kaliberov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergey A. Kaliberov. The network helps show where Sergey A. Kaliberov may publish in the future.

Co-authorship network of co-authors of Sergey A. Kaliberov

This figure shows the co-authorship network connecting the top 25 collaborators of Sergey A. Kaliberov. A scholar is included among the top collaborators of Sergey A. Kaliberov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergey A. Kaliberov. Sergey A. Kaliberov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	COX2/mPGES1/PGE ₂ pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cellsbreakdown → 2017 ·Proceedings of the National Academy of Sciences ·Victor Prima,Lyudmila N. Kaliberova,Sergey A. Kaliberov,David T. Curiel,Sergei Kusmartsev	374
2	Development of an adenovirus vector vaccine platform for targeting dendritic cells 2017 ·Cancer Gene Therapy ·Piyush Kumar Sharma,Igor P. Dmitriev,Elena A. Kashentseva,Geert Raes,Lijin Li,(unknown),(unknown),Jeffrey M. Arbeit,Timothy P. Fleming,Sergey A. Kaliberov,S. Peter Goedegebuure,David T. Curiel,William E. Gillanders	30
3	Functional Characterization of ATP-Binding Cassette Transporter A3 Mutations from Infants with Respiratory Distress Syndrome 2016 ·American Journal of Respiratory Cell and Molecular Biology ·Jennifer Wambach,Ping Yang,Daniel Wegner,Hillary B. Heins,Lyudmila N. Kaliberova,Sergey A. Kaliberov,David T. Curiel,Francis White,Aaron Hamvas,Brian P. Hackett,F. Sessions Cole	46
4	Retargeted adenoviruses for radiation-guided gene delivery 2016 ·Cancer Gene Therapy ·Sergey A. Kaliberov,Lyudmila N. Kaliberova,(unknown),Vaishali Kapoor,Dennis E. Hallahan	13
5	Retargeted oncolytic adenovirus displaying a single variable domain of camelid heavy-chain-only antibody in a fiber protein 2015 ·Molecular Therapy — Oncolytics ·Elisabeth A. van Erp,Lyudmila N. Kaliberova,Sergey A. Kaliberov,David T. Curiel	18
6	The myeloid-binding peptide adenoviral vector enables multi-organ vascular endothelial gene targeting 2014 ·Laboratory Investigation ·Zhi Hong Lu,Sergey A. Kaliberov,Jingzhu Zhang,Barbara Muz,Abdel Kareem Azab,Rebecca Sohn,Lyudmila N. Kaliberova,(unknown),David T. Curiel,Jeffrey M. Arbeit	18
7	Experimental virotherapy of chemoresistant pancreatic carcinoma using infectivity-enhanced fiber-mosaic oncolytic adenovirus 2014 ·Cancer Gene Therapy ·Sergey A. Kaliberov,Lyudmila N. Kaliberova,Donald J. Buchsbaum,David T. Curiel	4
8	Adenoviral targeting using genetically incorporated camelid single variable domains 2014 ·Laboratory Investigation ·Sergey A. Kaliberov,Lyudmila N. Kaliberova,Maurizio Buggio,Jacqueline M. Tremblay,Charles B. Shoemaker,David T. Curiel	13
9	Retargeting of gene expression using endothelium specific hexon modified adenoviral vector 2013 ·Virology ·Sergey A. Kaliberov,Lyudmila N. Kaliberova,Zhi Hong Lu,Meredith A. Preuss,Justin Barnes,Cecil R. Stockard,William E. Grizzle,Jeffrey M. Arbeit,David T. Curiel	20
10	Cancer Treatment with Gene Therapy and Radiation Therapy 2012 ·Advances in cancer research ·Sergey A. Kaliberov,Donald J. Buchsbaum	61
11	Experimental cancer therapy using restoration of NAD+-linked 15-hydroxyprostaglandin dehydrogenase expression 2009 ·Molecular Cancer Therapeutics ·Lyudmila N. Kaliberova,Sergei Kusmartsev,Valentina Krendelchtchikova,Cecil R. Stockard,William E. Grizzle,Donald J. Buchsbaum,Sergey A. Kaliberov	26
12	CRAdRGDflt-IL24 virotherapy in combination with chemotherapy of experimental glioma 2009 ·Cancer Gene Therapy ·Lyudmila N. Kaliberova,Valentina Krendelchtchikova,(unknown),Cecil R. Stockard,(unknown),James M. Markert,G. Yancey Gillespie,William E. Grizzle,Donald J. Buchsbaum,Sergey A. Kaliberov	26
13	Mutation of Escherichia coli cytosine deaminase significantly enhances molecular chemotherapy of human glioma 2007 ·Gene Therapy ·Sergey A. Kaliberov,(unknown),G. Yancey Gillespie,Valentina Krendelchtchikova,Dipankar Manna,Jeffrey C. Sellers,Lyudmila N. Kaliberova,Margaret E. Black,Donald J. Buchsbaum	26
14	Combination of cytosine deaminase suicide gene expression with DR5 antibody treatment increases cancer cell cytotoxicity 2005 ·Cancer Gene Therapy ·Sergey A. Kaliberov,(unknown),Lyudmila N. Kaliberova,Valentina Krendelchtchikova,Dipankar Manna,Tong Zhou,Donald J. Buchsbaum	21
15	Gene delivery and gene therapy of prostate cancer 2005 ·Expert Opinion on Drug Delivery ·Sergey A. Kaliberov,Donald J. Buchsbaum	4
16	Adenovirus-mediated FLT1-targeted proapoptotic gene therapy of human prostate cancer 2004 ·Molecular Therapy ·Sergey A. Kaliberov,Lyudmila N. Kaliberova,Cecil R. Stockard,William E. Grizzle,Donald J. Buchsbaum	21
17	Combined ionizing radiation and sKDR gene delivery for treatment of prostate carcinomas 2004 ·Gene Therapy ·Sergey A. Kaliberov,Lyudmila N. Kaliberova,Donald J. Buchsbaum	19
18	Enhanced apoptosis following treatment with TRA-8 anti-human DR5 monoclonal antibody and overexpression of exogenous Bax in human glioma cells 2004 ·Gene Therapy ·Sergey A. Kaliberov,(unknown),Lyudmila N. Kaliberova,Tong Zhou,Donald J. Buchsbaum	13
19	Adenovirus-Mediated Transfer of BAX Driven by the Vascular Endothelial Growth Factor Promoter Induces Apoptosis in Lung Cancer Cells 2002 ·Molecular Therapy ·Sergey A. Kaliberov,Donald J. Buchsbaum,G. Yancey Gillespie,David T. Curiel,Waleed Arafat,Mark Carpenter,Murray Stackhouse	27
20	[The immunity indices in the infection of mice of different strains with the Machupo virus]. 1993 ·PubMed ·(unknown),(unknown),Sergey A. Kaliberov,Larisa Pereboeva,(unknown),Elena A. Kashentseva	1

About Sergey A. Kaliberov

Sergey A. Kaliberov is a scholar working on Biotechnology, Genetics and Oncology, having authored 25 papers that have together received 825 indexed citations. Recurring topics across this work include Virus-based gene therapy research (18 papers), Cancer Research and Treatments (9 papers) and CAR-T cell therapy research (8 papers). The work is most often cited by research in Immunology (273 citations), Biotechnology (97 citations) and Oncology (304 citations). Sergey A. Kaliberov has collaborated with scholars based in United States, United Kingdom and Belgium. Frequent co-authors include Lyudmila N. Kaliberova, David T. Curiel, Sergei Kusmartsev, Victor Prima, Donald J. Buchsbaum, Valentina Krendelchtchikova, Cecil R. Stockard, William E. Grizzle, Jeffrey M. Arbeit and G. Yancey Gillespie. Their work appears in journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact